Publications by authors named "Benjamin M Weide"

Claim this Profile
A
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
Thomas K Eigentler, Anne Kamin, Benjamin M Weide, Helmut Breuninger, Ulrich M Caroli

J Am Acad Dermatolยท October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis